MARKET

SNSE

SNSE

Sensei Biotherapeutics, Inc.
NASDAQ
13.00
-1.65
-11.26%
After Hours: 13.00 0 0.00% 18:05 06/08 EDT
OPEN
14.81
PREV CLOSE
14.65
HIGH
14.85
LOW
12.63
VOLUME
49.55K
TURNOVER
--
52 WEEK HIGH
36.76
52 WEEK LOW
5.60
MARKET CAP
17.45M
P/E (TTM)
-0.0911
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 1d ago
Weekly Report: what happened at SNSE last week (0601-0605)?
Weekly Report · 1d ago
Analysts Offer Insights on Healthcare Companies: Sensei Biotherapeutics (SNSE) and Kura Oncology (KURA)
TipRanks · 4d ago
Sensei Biotherapeutics grants options for 19,300 shares at $19.79 under 2026 inducement plan
PUBT · 5d ago
SENSEI BIOTHERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 5d ago
Where short sellers are betting in micro- and small-cap stocks
Seeking Alpha · 5d ago
Most and least shorted healthcare stocks with market cap up to $2B at the end of May
Seeking Alpha · 6d ago
Dual Insider Moves Shake Up Sensei Biotherapeutics Investor Watch
TipRanks · 06/02 02:12
More
About SNSE
Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients. The Company's lead program is PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. The Company is also completing a Phase I/II trial of solnerstotug, its V-domain Ig suppressor of T cell activation (VISTA) inhibitor, in patients with advanced solid tumors. Its TMAb platform is designed to enable highly selective targeting through conditional antibody activation of immune cells in the tumor microenvironment without on-target, off-tumor activity. Its programs include Solnerstotug (SNS-101), SNS-102, SNS-103, and SNS-201. Solnerstotug is a conditionally active, human monoclonal IgG1 antibody designed to block the VISTA checkpoint, which acts as a suppressor of T cells by binding the receptor PSGL-1.

Webull offers Sensei Biotherapeutics Inc stock information, including NASDAQ: SNSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNSE stock methods without spending real money on the virtual paper trading platform.